• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 4 of 12
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceValeant Bond Holders Say the Company Is In Default
By ReutersJune 3, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
FinanceValeant to Report Results on June 7
By ReutersJune 1, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceWells Fargo Just Cut Its Valeant Estimates Because of Executive Bonuses
By Lucinda ShenMay 18, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthValeant Is Raising Discounts on Expensive Drugs
By ReutersMay 16, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceHospitals Say Valeant Isn’t Meeting Its Discount Promise
By Lucinda ShenMay 12, 2016
Fortune Global Forum 2015
LeadershipMeet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
FinanceValeant to File Earnings Ahead of Deadline
By ReutersMay 9, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
FinanceBiotech Stocks Are Down 25% So Far This Year
By Sy MukherjeeMay 6, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceWhy Bill Ackman Regrets Buying Valeant
By Lucinda ShenMay 2, 2016
Berkshire Hathaway Inc. Annual General Meeting
FinanceWarren Buffett: Valeant’s Business Model Was “Deeply Flawed”
By Stephen GandelApril 30, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceValeant Files Much Delayed Annual Earnings Saying It’s “Cured”
By Lucinda ShenApril 29, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
LeadershipValeant’s New CEO Could Pull in $500 Million
By Ian MountApril 28, 2016
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
Exclusive: The Woman Behind the ‘Female Viagra’ Has a New Venture
MPWExclusive: The Woman Behind the ‘Female Viagra’ Has a New Venture
By Kristen BellstromApril 27, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthHouse Democrats Want to Know if Valeant Is Withholding Documents
By ReutersApril 26, 2016
1
  • 2
  • 3
  • 4
  • 5
  • 6
...12
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPECplaceholder alt text
By Shawn TullyApril 29, 2026
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’placeholder alt text
By Eleanor PringleApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.